CBM? Another cannabinoid for diabetes?

Could cannabis help treat diabetes? A small but growing body of research suggests that certain cannabinoids may hold promise.
In a study published in the journal Molecules, researchers from the Institute of Biomolecular Chemistry in Italy have found that cannabimovone (CBM), a rare cannabinoid, can sensitize cells to insulin. CBM thus joins CBD, THC, THCV, and THCA as a potentially promising avenue of research for diabetes prevention.  The Italian researchers were interested in THC and CBD’s insulin-sensitizing effects and wondered if there were any other cannabinoids that might do the same with fewer side effects. Using computer modeling, they searched their cannabinoid database, and there it was: CBM fit into the model.
​Makes one wonder what else does cannabis have in its arsenal of healing.